Brief: Biodexa Announces Positive Phase 2 Clinical Trial Results Of Erapa™ At 12 Months In Familial Adenomatous Polyposis

Biodexa Pharmaceuticals

24/06/2024 15:36

June 24 (Reuters) - Biodexa Pharmaceuticals PLC
 5MPy.F :
    * BIODEXA ANNOUNCES POSITIVE PHASE 2 CLINICAL TRIAL RESULTS
OF
ERAPA™ AT 12 MONTHS IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP)
    * BIODEXA PHARMACEUTICALS PLC - BIODEXA'S ERAPA™ PHASE 3
STUDY
BACKED BY $17M GRANT
    * BIODEXA PHARMACEUTICALS PLC: OVERALL 75% NON-PROGRESSION
RATE AT
12 MONTHS IN TRIAL
    * BIODEXA PHARMACEUTICALS: STUDY SHOWS OVERALL 75%
NON-PROGRESSION
RATE AT 12 MONTHS

Source text for Eikon:  ID:nGNX3QC1N1 
Further company coverage:  5MPy.F 

 ((Reuters.Briefs@thomsonreuters.com;))